| 000 | 01817 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250513222658.0 | ||
| 264 | 0 | _c20010201 | |
| 008 | 200102s 0 0 eng d | ||
| 022 | _a0923-7534 | ||
| 024 | 7 |
_a10.1023/a:1008363601515 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBaars, A | |
| 245 | 0 | 0 |
_aSkin tests predict survival after autologous tumor cell vaccination in metastatic melanoma: experience in 81 patients. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cAug 2000 |
||
| 300 |
_a965-70 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xadministration & dosage |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBCG Vaccine _xadministration & dosage |
| 650 | 0 | 4 |
_aCancer Vaccines _xadministration & dosage |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHypersensitivity, Delayed |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelanoma _ximmunology |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 |
_aSkin Neoplasms _ximmunology |
| 650 | 0 | 4 | _aSkin Tests |
| 650 | 0 | 4 |
_aSkin Ulcer _xetiology |
| 700 | 1 | _aClaessen, A M | |
| 700 | 1 | _avan den Eertwegh, A J | |
| 700 | 1 | _aGall, H E | |
| 700 | 1 | _aStam, A G | |
| 700 | 1 | _aMeijer, S | |
| 700 | 1 | _aGiaccone, G | |
| 700 | 1 | _aMeijer, C J | |
| 700 | 1 | _aScheper, R J | |
| 700 | 1 | _aWagstaff, J | |
| 700 | 1 | _aVermorken, J B | |
| 700 | 1 | _aPinedo, H M | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 11 _gno. 8 _gp. 965-70 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1023/a:1008363601515 _zAvailable from publisher's website |
| 999 |
_c10983082 _d10983082 |
||